Risk factors for anti-inflammatory-drug- or aspirin-induced gastrointestinal complications in individuals receiving outpatient physical therapy services

Journal of Orthopaedic and Sports Physical Therapy

Volumn 32, Issue 10, 2002, Pages 510-517

  Boissonnault, William G ^a   Meek, Patrick D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Anti inflammatory drug; Aspirin; Gastrointestinal complications; Physical therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTIINFLAMMATORY AGENT; CIMETIDINE; CORTICOSTEROID; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; KETOPROFEN; MISOPROSTOL; NAPROXEN; NON PRESCRIPTION DRUG; PROTON PUMP INHIBITOR; RANITIDINE; WARFARIN;

ABDOMINAL PAIN; ADULT; AGED; AGING; AMBULATORY CARE; ANEMIA; ARTICLE; DYSPEPSIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HEART DISEASE; HEARTBURN; HEMATEMESIS; HEMATOCHEZIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MELENA; NAUSEA; PEPTIC ULCER; PHYSIOTHERAPY; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK FACTOR; ULCER PERFORATION; VOMITING;

EID: 0036810936     PISSN: 01906011     EISSN: None     Source Type: Journal    
DOI: 10.2519/jospt.2002.32.10.510     Document Type: Article

References (32)

1. American Physical Therapy Association. Guide to Physical Therapist Practice. 2nd Ed. Phys Ther. 2001;81:9-746.
2. Battie MC, Cherkin DC, Dunn R, Ciol MA, Wheeler KJ. Managing low back pain: Attitudes and treatment preferences of physical therapists. Phys Ther. 1994;74:219-226.
3. Bjorkman DJ. Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: Risk factors and frequency of complications. Am J Med. 1999;107:3S-8S; discussion 8S-10S.
4. Boissonnault WG, Koopmeiners MB. Medical history profile: Orthopaedic physical therapy outpatients. J Orthop Sports Phys Ther. 1994;20:2-10.
5. Boissonnault WG. Prevalence of comorbid conditions, surgeries, and medication use in a physical therapy outpatient population: A multicentered study. J Orthop Sports Phys Ther. 1999;29:506-519; discussion 520-525.
6. Brook RD, Kramer MB, Blaxall BC, Bisognano JD. Nonsteroidal anti-inflammatory drugs and hypertension. J Clin Hypertens (Greenwich). 2000;2:319-323.
7. Chitturi S, Farrell GC. Drug-induced cholestasis. Semin Gastrointest Dis. 2001;12:113-124.
8. de Abajo FJ, Garcia Rodriguez LA. Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin Pharmacol. 2001;1:1.
9. Di Fabio RP, Boissonnault W. Physical therapy and health-related outcomes for patients with common orthopaedic diagnoses. J Orthop Sports Phys Ther. 1998;27:219-230.
10. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345:433-442.
11. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:769-772.
12. Garcia Rodriguez LA, Perez Gutthann S. Use of the UK general practice research database for pharmacoepidemiology. Br J Clin Pharmacol. 1998;45:419-425.
13. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol. 2000;151:488-496.
14. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 1993;105:1078-1088.
15. Jette AM, Davis KD. A comparison of hospital-based and private outpatient physical therapy practices. Phys Ther. 1991;71:366-375; discussion 376-381.
16. Jette AM, Smith K, Haley SM, Davis KD. Physical therapy episodes of care for patients with low back pain. Phys Ther. 1994;74:101-110; discussion 110-115.
17. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology. 2001;120:594-606.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
19. Medical Manager Billing Report [Data on File]. Memphis, TN: Physiotherapy Associates, Inc.; 1998.
20. National Institute on Alcohol Abuse and Alcoholism. The Physicians' Guide to Helping Patients with Alcohol Problems. Washington, DC: Government Printing Office; 1995.
21. Nelson C. Physiotherapy Office Visits: National Ambulatory Medical Care Survey, United States, 1980-1981. Washington, DC: National Center for Health Statistics, US Dept of Health and Human Services; 1986.
22. Rockey DC. Occult gastrointestinal bleeding. N Engl J Med. 1999;341:38-46.
23. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995;123:241-249.
24. Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med. 1996;156:1530-1536.
25. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105:31S-38S.
26. Singh G, Rosen Ramey D. NSAID induced gastrointestinal complications: The ARAMIS perspective - 1997. Arthritis, rheumatism, and aging medical information system. J Rheumatol Suppl. 1998;51:8-16.
27. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol. 1999;26 Suppl 56:18-24.
28. Soll A, Isenberg J. Peptic ulcer disease: Epidemiology, pathophysiology, clinical manifestations, and diagnosis. In: Goldman L, Bennett JC, eds. Cecil Textbook of Medicine. 21st Ed. Philadelphia, PA: WB Saunders; 2000:671-675.
29. Spigset O, Hagg S. Analgesics and breast-feeding: Safety considerations. Paediatr Drugs. 2000;2:223-238.
30. Szczeklik A. Antipyretic analgesics and the allergic patient. Am J Med. 1983;75:82-84.
31. Wara P, Stodkilde H. Bleeding pattern before admission as guideline for emergency endoscopy. Scand J Gastroenterol. 1985;20:72-78.
32. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1999;340:1888-1899.